John Feneck: Why Gold is Down, 10+ Mining Stocks on My Radar Now
John Feneck, portfolio manager and consultant at Feneck Consulting, shared his thoughts on gold’s post-US election price drop, saying it...
How to Invest in Chromium Stocks (Updated 2024)
Chromium is a metal for the modern age with a bright future. It is one of the more durable metals...
Russia Restricts US Uranium Exports, Retaliating to American Ban
The Russian government has imposed temporary restrictions on enriched uranium exports to the US. Announced on November 15, the move...
Elon Musk’s X Corp. files notice in Alex Jones’ Infowars bankruptcy case
Attorneys for X Corp., the firm established by Elon Musk to take over Twitter, filed a notice of appearance on...
TNT’s ‘Inside the NBA’ headed for ESPN and ABC after Warner Bros. Discovery settlement
Warner Bros. Discovery agreed to end its quest to own a package of live National Basketball Association games in the U.S....
AMC is poised to ride the box office rebound, as long as its debt doesn’t get in the way
The domestic box office is on the rebound, having posted its highest third-quarter ticket sales since the pandemic. The world’s...
BPH Energy LimitedInvestee Cortical Dynamics Presentation
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation...
Positive Feasibility Study Demonstrates Profitable Magnet Recycling Business in UK
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the...
68Ga-RAD 301 (68Ga-Trivehexin) Demonstrates Strong Potential for Imaging of αvβ6-Integrin Expression in Pancreatic Cancer Patients
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of...
Radiopharm Theranostics CEO Shares Company Milestones as NASDAQ Listing Nears
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and...
